Results 231 to 240 of about 1,728,986 (343)

Quality-Adjusted Life-Years Lost Due to Physical Inactivity in a US Population With Osteoarthritis. [PDF]

Arthritis Care Res (Hoboken), 2020
Losina E, Silva GS, Smith KC, Collins JE, Hunter DJ, Shrestha S, Messier SP, Yelin EH, Suter LG, Paltiel AD, Katz JN.   +10 more
europepmc   +1 more source

Quality-Adjusted Life Years and Disability-Adjusted Life Years Are Better With Concurrent Chemoradiation Therapy Than Induction Chemotherapy Followed by Chemoradiation Therapy in Nasopharyngeal Carcinoma. [PDF]

Cureus, 2021
Nittala MR, Kanakamedala MR, Mundra E, Woods WC, Smith ML, Hamilton RD, Jefferson GD, Jackson L, Packianathan S, Vijayakumar S.   +9 more
europepmc   +1 more source

Are Quality-Adjusted Life Years a Good Proxy Measure of Individual Capabilities? [PDF]

, 2017
Paul Mitchell, Sridhar Venkatapuram, Jeff Richardson, Angelo Iezzi, Joanna Coast   +4 more
openalex   +1 more source

Air Pollution and the Risk and Progression of Multiple Sclerosis: A Systematic Review and Meta‐Analysis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Purpose Air pollution has been linked to several neurological conditions, including stroke and neurodegenerative diseases. Evidence regarding its association with multiple sclerosis (MS) remains conflicting, limited by small sample sizes. Methods PubMed, Embase, Scopus, and Cochrane controlled register of trials (CENTRAL) were searched on ...
Ahmad A. Toubasi, Thuraya N. Al‐Sayegh
wiley   +1 more source

Quality-adjusted life years and surgical waiting list: Systematic review of the literature. [PDF]

World J Gastrointest Surg
de la Plaza Llamas R, Ortega Azor L, Hernández Yuste M, Gorini L, Latorre-Fragua RA, Díaz Candelas DA, Al Shwely Abduljabar F, Gemio Del Rey IA.   +7 more
europepmc   +1 more source

Gain in Quality-adjusted Life-years in Patients with Rheumatoid Arthritis During 1 Year of Biological Therapy: A Prospective Study in Clinical Practice [PDF]

, 2013
Louise Linde, Jan Sørensen, Mikkel Østergaard, Merete Lund Hetland   +3 more
openalex   +1 more source

Structure–Function Decoupling of the Sensorimotor and Default Mode Networks in Black Americans With MS

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background and Objectives Multiple sclerosis (MS) exhibits racially disparate rates of disease progression. Black people with MS (B‐PwMS) experience a more severe disease course than non‐Hispanic White people with MS (NHW‐PwMS). Here we investigated structural and functional connectivity as well as structure–function decoupling in the ...
Emilio Cipriano, Giacomo Boffa, Maria Petracca, Marta Ponzano, Nicole Graziano, Claire Wigley, Claire Riley, Jonathan Howard, Pietro Bontempi, Sylvia Klineova, Fred Lublin, Matilde Inglese   +11 more
wiley   +1 more source

The Impacts of COVID-19 Restrictions on Quality Adjusted Life Years (QALY): Heterogeneous effects and post-pandemic recovery. [PDF]

PLoS One
Atal R, Bedregal P, Carrasco JA, González F, Harrison R, Vizcaya C.   +5 more
europepmc   +1 more source

Validity of a Wearable Digital Insole for Assessing Gait ON and OFF in Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Gait impairment is a distinctive symptom of Parkinson's disease that negatively impact mobility. We assessed the validity of wearable digital insoles against a validated reference gait analysis system for measuring select gait characteristics in patients with Parkinson's disease. Methods A comparative analysis between digital insoles
Deborah A. Hall, Kimberly Kwei, Rolando J. Acosta, Bharatkumar Koyani, Erin Robertson, Pratyush Rai, Roland Barge, Emily Timm, Nicollette L. Purcell, Natasha Desai, Dhanesh Patel, Ana‐Maria Visoiu‐Knapp, Samuel Stuart, Rinol Alaj, Matthew F. Wipperman, Oren Levy, Joan A. O'Keefe   +16 more
wiley   +1 more source

Base-case model analyses of life-years gained (LYGs), quality-adjusted life-years (QALYs), costs and incremental cost per LYG/QALY of maintenance gefitinib therapy arm and placebo arm after four cycles of stand first-line platinum-based chemotherapy for patients with locally advanced/metastatic NSCLC, on the basis of 1000 simulation cases.

, 2015
Xiaohui Zeng, Jianhe Li, Peng Liubao, Yunhua Wang, Tan Chongqing, Gannong Chen, Wan Xiaomin, Qiong Lu, Lidan Yi   +8 more
openalex   +2 more sources